[go: up one dir, main page]

BRPI0411688A - antibióticos de oxazolidinona substituìda de grupo de ciclopropil e seus derivados - Google Patents

antibióticos de oxazolidinona substituìda de grupo de ciclopropil e seus derivados

Info

Publication number
BRPI0411688A
BRPI0411688A BRPI0411688-7A BRPI0411688A BRPI0411688A BR PI0411688 A BRPI0411688 A BR PI0411688A BR PI0411688 A BRPI0411688 A BR PI0411688A BR PI0411688 A BRPI0411688 A BR PI0411688A
Authority
BR
Brazil
Prior art keywords
derivatives
substituted oxazolidinone
group substituted
cyclopropyl group
antibiotics
Prior art date
Application number
BRPI0411688-7A
Other languages
English (en)
Inventor
Yasumichi Fukuda
Original Assignee
Merck & Co Inc
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Kyorin Seiyaku Kk filed Critical Merck & Co Inc
Publication of BRPI0411688A publication Critical patent/BRPI0411688A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"ANTIBIóTICOS DE OXAZOLIDINONA SUBSTITUìDA DE GRUPO DE CICLOPROPIL E SEUS DERIVADOS". Esta invenção está relacionada a novas oxazolidinonas, que possuem metade de ciclopropil, que são eficazes contra patogêneses aeróbicas e anaeróbicas, como estafilococos, estreptococos e enterococos multi-resistentes espécie de Bacterióides spp., de Clostridia spp., bem como organismos de ácido rápido como Mycobacterium tuberculosis e outras espécies de micobactérias. Os compostos são representados pela fórmula estrutural (I) : seu enantiónero, diastereómero ou sal ou éster aceitável farmaceuticamente.
BRPI0411688-7A 2003-07-02 2004-06-29 antibióticos de oxazolidinona substituìda de grupo de ciclopropil e seus derivados BRPI0411688A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48390403P 2003-07-02 2003-07-02
US54698404P 2004-02-24 2004-02-24
PCT/US2004/020734 WO2005005398A2 (en) 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof

Publications (1)

Publication Number Publication Date
BRPI0411688A true BRPI0411688A (pt) 2006-12-26

Family

ID=34068173

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411688-7A BRPI0411688A (pt) 2003-07-02 2004-06-29 antibióticos de oxazolidinona substituìda de grupo de ciclopropil e seus derivados

Country Status (23)

Country Link
US (2) US7462633B2 (pt)
EP (1) EP1646629B1 (pt)
JP (1) JP4607107B2 (pt)
KR (1) KR20060113625A (pt)
AR (1) AR044990A1 (pt)
AT (1) ATE471937T1 (pt)
AU (1) AU2004256083B2 (pt)
BR (1) BRPI0411688A (pt)
CA (1) CA2530140C (pt)
CL (1) CL2004001678A1 (pt)
DE (1) DE602004027811D1 (pt)
EC (1) ECSP056257A (pt)
IL (1) IL172785A0 (pt)
IS (1) IS8178A (pt)
MA (1) MA27938A1 (pt)
MX (1) MXPA06000228A (pt)
MY (1) MY140137A (pt)
NO (1) NO20060558L (pt)
NZ (1) NZ544237A (pt)
PE (1) PE20050732A1 (pt)
RU (1) RU2348628C2 (pt)
TW (1) TW200510421A (pt)
WO (1) WO2005005398A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002360238B2 (en) * 2001-04-17 2007-11-15 Kyorin Pharmaceutical Co., Ltd. Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
US8324398B2 (en) * 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
AR045690A1 (es) 2003-06-03 2005-11-09 Rib X Pharmaceuticals Inc Compuestos biaril heterociclicos y metodos para preparar y utilizar los mismos
WO2005005398A2 (en) 2003-07-02 2005-01-20 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
AU2004256086B2 (en) * 2003-07-02 2007-12-06 Kyorin Pharmaceutical Co., Ltd. Oxazolidinone antibiotics and derivatives thereof
EP1713785A1 (en) * 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2006038100A1 (en) * 2004-10-08 2006-04-13 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
US8399660B2 (en) * 2005-06-08 2013-03-19 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
US20090018123A1 (en) * 2005-06-20 2009-01-15 Milind D Sindkhedkar Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders
AR054608A1 (es) * 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
AU2008260647A1 (en) * 2007-05-23 2008-12-11 Merck Sharp & Dohme Corp. Cyclopropyl pyrrolidine orexin receptor antagonists
MX366793B (es) 2008-10-10 2019-07-24 Merck Sharp & Dohme Corp Star Metodos para preparar oxazolidinonas y composiciones que las contienen.
ES2734724T3 (es) 2009-02-03 2019-12-11 Merck Sharp & Dohme Forma cristalina de dihidrogenofosfato de (R)-3-(4-(2-(2-metiltetrazol-5-il)piridin-5-il)-3-fluorofenil)-5-hidroximetiloxazolidin-2-ona
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
RU2012102094A (ru) 2009-06-26 2013-08-10 Панацеа Биотек Лтд. Новые азабициклогексаны
JP2013542929A (ja) 2010-09-28 2013-11-28 パナセア バイオテック リミテッド 新規ビシクロ環化合物
WO2017066964A1 (en) 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
US12109203B2 (en) 2018-07-25 2024-10-08 Zydus Lifesciences Limited Substituted oxazolidinones for the treatment of mammalian infections
US20220289751A1 (en) * 2019-07-17 2022-09-15 Ono Pharmaceutical Co., Ltd. Compound having kdm5 inhibitory activity and pharmaceutical use thereof
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053593A (en) * 1975-11-26 1977-10-11 Lew Frumoff Medical product combining antimicrobial, antiporasitic and vitamin complex
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
KR100257418B1 (ko) * 1991-11-01 2000-05-15 로렌스 티. 마이젠헬더 치환된 아릴-및 헤테로아릴-페닐옥사졸리디논
DE69316240T2 (de) * 1992-12-08 1998-05-20 Upjohn Co Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel
TW286317B (pt) * 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
DK0828741T3 (da) 1995-05-11 2001-11-26 Upjohn Co Spirocykliske og bicykliske diazinyl- og carbazinyloxazolidinoner
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
DE60035330T2 (de) 1999-05-14 2008-03-06 Kabushiki Kaisha Toshiba, Kawasaki Oberflächenwellenfilter
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
WO2001058885A1 (en) 2000-02-10 2001-08-16 Pharmacia & Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
MXPA02012045A (es) 2000-06-05 2003-10-15 Dong A Pharm Co Ltd Nuevos derivados de oxazolidinona y proceso para su preparacion.
HUP0302918A2 (hu) 2000-07-17 2003-12-29 Ranbaxy Laboratories Limited Mikrobaellenes oxazolidinonszármazékok és a vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
WO2002027029A2 (en) * 2000-09-27 2002-04-04 Lynx Therapeutics, Inc. Method for determining relative abundance of nucleic acid sequences
JP2004518677A (ja) 2000-12-21 2004-06-24 ファルマシア・アンド・アップジョン・カンパニー 抗菌性キノロン誘導体および細菌感染を治療するためのその使用
YU52403A (sh) 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
AU2002360238B2 (en) * 2001-04-17 2007-11-15 Kyorin Pharmaceutical Co., Ltd. Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
WO2003048136A1 (en) 2001-11-29 2003-06-12 Merck & Co., Inc. Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof
CN1155585C (zh) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5－取代噁唑烷酮衍生物及其制备方法和应用
TW200302095A (en) 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
AU2003207340A1 (en) 2002-02-28 2003-09-09 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
US20050209248A1 (en) 2002-05-15 2005-09-22 Biswajit Das Plymorphic forms of phenyl oxazolidinone derivatives
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
KR20050084010A (ko) * 2002-11-28 2005-08-26 아스트라제네카 아베 항균제로서의 옥사졸리디논
TW200500360A (en) * 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
JP2006522791A (ja) * 2003-04-09 2006-10-05 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗微生物性［３．１．０］ビシクロヘキシルフェニルオキサゾリジノン誘導体および類似体
WO2004099199A1 (en) 2003-05-06 2004-11-18 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
US20070185132A1 (en) * 2003-07-02 2007-08-09 Yasumichi Fukuda Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo
AU2004256086B2 (en) 2003-07-02 2007-12-06 Kyorin Pharmaceutical Co., Ltd. Oxazolidinone antibiotics and derivatives thereof
AU2004256084B2 (en) 2003-07-02 2007-10-18 Kyorin Pharmaceutical Co., Ltd. Oxazolidinone antibiotics and derivatives thereof
WO2005005398A2 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof

Also Published As

Publication number Publication date
CL2004001678A1 (es) 2005-05-20
IL172785A0 (en) 2006-06-11
US20050038092A1 (en) 2005-02-17
NZ544237A (en) 2008-09-26
JP4607107B2 (ja) 2011-01-05
DE602004027811D1 (de) 2010-08-05
MXPA06000228A (es) 2006-06-27
ATE471937T1 (de) 2010-07-15
CA2530140C (en) 2010-11-09
AU2004256083B2 (en) 2007-10-11
KR20060113625A (ko) 2006-11-02
MY140137A (en) 2009-11-30
WO2005005398A3 (en) 2005-04-28
NO20060558L (no) 2006-02-02
CA2530140A1 (en) 2005-01-20
AR044990A1 (es) 2005-10-12
EP1646629A2 (en) 2006-04-19
AU2004256083A1 (en) 2005-01-20
PE20050732A1 (es) 2005-11-02
US7582659B2 (en) 2009-09-01
WO2005005398A2 (en) 2005-01-20
ECSP056257A (es) 2006-04-19
TW200510421A (en) 2005-03-16
US7462633B2 (en) 2008-12-09
IS8178A (is) 2005-12-13
EP1646629B1 (en) 2010-06-23
JP2007521281A (ja) 2007-08-02
US20070203187A1 (en) 2007-08-30
MA27938A1 (fr) 2006-06-01
RU2005140379A (ru) 2007-08-10
RU2348628C2 (ru) 2009-03-10

Similar Documents

Publication Publication Date Title
BRPI0411688A (pt) antibióticos de oxazolidinona substituìda de grupo de ciclopropil e seus derivados
FI971774A0 (fi) Antimikrobaalisia fenyylioksatsolidinoniyhdisteitä
EA200500283A1 (ru) Производные оксазолидинона как противомикробные средства
DK0717738T3 (da) Substituerede oxazin- og thiazin-oxazolidinonantimikrobielle midler
DK1699784T3 (da) Nye oxazolidinonderivater
DE60206154D1 (de) Bicyclo[3,1,0]hexan als strukturelement enthaltende oxazolidinon-antibiotika und deren derivate
BR122012009489B8 (pt) processo para produzir 2-etóxi-1-{[2’-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso
UY28211A1 (es) Compuestos de hidroximetilo
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
CZ288788B6 (cs) Antibakteriální fenyloxazolidinony substituované troponem
CA2236677A1 (en) 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents
ZA968661B (en) Oxazolidinone antibacterial agent with tricyclic substituents.
PE20200333A1 (es) Compuestos y metodos para tratar infecciones bacterianas
PE20080283A1 (es) Profarmacos antimicrobianos de oxazolidinona
NO20070870L (no) Oksazolidinonforbindelser og sammensetninger og fremgangsmater relatert dertil
BR0308643A (pt) Composto do derivado do ácido piridobenzoxazina carboxìlico e agente antibacteriano contendo o mesmo
MX9703040A (es) Antimicrobianos de feniloxazolidinona.
PE20090505A1 (es) Proceso para preparar oxazolidina- y oxazolidinona-aminodioles
NO20071230L (no) Oksazolidinoner inneholdende oksindoler som antibakterielle midler
PE20080213A1 (es) Derivados del acido fenilacetico como inhibidores de la ciclooxigenasa-2
WO2006018682A3 (en) Oxazolidinone derivatives as antimicrobials
UA88448C2 (ru) Оксазолидиноновые антибиотики с замещенной циклопропильной группой и их производные
ES2054829T3 (es) Antibioticos del grupo mureidomicina, su preparacion y su empleo.
RU2011103485A (ru) Оксазолидиноновые соединения, фармацевтическая композиция на их основе, способ получения оксазолидиноновых соединений и способ лечения бактериальных инфекций
DOP2004000942A (es) Antibióticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos (cyclopropyl group substitued oxazoldinone antibiotics and derivatives thereof)

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: KYORIN PHARMACEUTICAL CO., LTD. (JP) , MERCK SHARP

Free format text: NOME ALTERADO DE: MERCK AND CO., INC.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.